Loading...
Femara
Antineoplastic • Aromatase inhibitor
Competitive, non-steroidal aromatase inhibitor that blocks estrogen synthesis
Drug Class
Antineoplastic
Subclass
Aromatase inhibitor
Half-life
48 hours
Time for plasma concentration to decrease by 50%
Protein Binding
60%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses